Поиск по российской офтальмологии
Найдено 3 результатов
Будзинская Мария Викторовна – ФГБНУ "НИИГБ им. М.М. Краснова"
Ophthalmology, phase III, Principal Investigator, 2020 – present time Protocol CRTH258D2301 "A 96-week, randomized, single-blind, multicenter, phase III study to evaluate the efficacy and safety of 6 mg brolucizumab... Ophthalmology, phase III, Principal Investigator, 2020 – 2021 Protocol CRTH258C2301 “An 18-month, randomized, multicenter, double-blind, phase III trial to evaluate the efficacy and safety of brolucizumab...
Статья Препарат Novartis для лечения ВМД связан с редкими побочными эффектами со стороны сетчатки
Karle et al, Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events, Science Translational Medicine (2023).... Kearns et al, A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab, Science Translational Medicine (2023)....
Статья Клиническое исследование CONDOR: бролуцизумаб превосходит панретинальную фотокоагуляцию при пролиферативной диабетической ретинопатии
Brolucizumab in the treatment of proliferative diabetic retinopathy: the CONDOR randomized clinical trial. JAMA Ophthalmol.... Brolucizumab: evolution through preclinical and clinical studies and the implications for the management of neovascular age-related macular degeneration....